Through its caspase-3-dependent activation and pore-forming capacity, GSDME converts apoptotic signals into secondary pyroptosis, amplifying tissue inflammation and injury in conditions such as atherosclerosis, myocardial infarction, cardiomyopathy, and pulmonary hypertension. Here, CASP3 is linked to pulmonary hypertension.